<i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction

Gastric cancer is ranked fifth in cancer list and has the third highest mortality rate. <i>Helicobacter pylori</i> is a class I carcinogen and a predominant etiological factor of gastric cancer. <i>H. pylori</i> infection may induce carcinogenesis via epigenetic alterations i...

Full description

Bibliographic Details
Main Authors: Jibran Sualeh Muhammad, Mohamed Ahmed Eladl, Ghalia Khoder
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/8/1/23
_version_ 1818039797118140416
author Jibran Sualeh Muhammad
Mohamed Ahmed Eladl
Ghalia Khoder
author_facet Jibran Sualeh Muhammad
Mohamed Ahmed Eladl
Ghalia Khoder
author_sort Jibran Sualeh Muhammad
collection DOAJ
description Gastric cancer is ranked fifth in cancer list and has the third highest mortality rate. <i>Helicobacter pylori</i> is a class I carcinogen and a predominant etiological factor of gastric cancer. <i>H. pylori</i> infection may induce carcinogenesis via epigenetic alterations in the promoter region of various genes. <i>H. pylori</i> is known to induce hypermethylation-silencing of several tumor suppressor genes in <i>H. pylori</i>-infected cancerous and <i>H. pylori</i>-infected non-cancerous gastric mucosae. This article presents a review of the published literature mainly from the last year 15 years. The topic focuses on <i>H. pylori</i>-induced DNA methylation linked to gastric cancer development. The authors have used MeSH terms &#8220;<i>Helicobacter pylori</i>&#8222; with &#8220;epigenetic,&#8222; &#8220;DNA methylation,&#8222; in combination with &#8220;gastric inflammation&#8222;, gastritis&#8222; and &#8220;gastric cancer&#8222; to search SCOPUS, PubMed, Ovid, and Web of Science databases. The success of epigenetic drugs such as de-methylating agents in the treatment of certain cancers has led towards new prospects that similar approaches could also be applied against gastric cancer. However, it is very important to understand the role of all the genes that have already been linked to <i>H. pylori</i>-induced DNA methylation in order to in order to evaluate the potential benefits of epigenetic drugs.
first_indexed 2024-12-10T08:04:20Z
format Article
id doaj.art-8c0440ff8d1d4573ac833532f5571a6b
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-12-10T08:04:20Z
publishDate 2019-02-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-8c0440ff8d1d4573ac833532f5571a6b2022-12-22T01:56:43ZengMDPI AGPathogens2076-08172019-02-01812310.3390/pathogens8010023pathogens8010023<i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future DirectionJibran Sualeh Muhammad0Mohamed Ahmed Eladl1Ghalia Khoder2Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, UAEDepartment of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, UAEDepartment of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, UAEGastric cancer is ranked fifth in cancer list and has the third highest mortality rate. <i>Helicobacter pylori</i> is a class I carcinogen and a predominant etiological factor of gastric cancer. <i>H. pylori</i> infection may induce carcinogenesis via epigenetic alterations in the promoter region of various genes. <i>H. pylori</i> is known to induce hypermethylation-silencing of several tumor suppressor genes in <i>H. pylori</i>-infected cancerous and <i>H. pylori</i>-infected non-cancerous gastric mucosae. This article presents a review of the published literature mainly from the last year 15 years. The topic focuses on <i>H. pylori</i>-induced DNA methylation linked to gastric cancer development. The authors have used MeSH terms &#8220;<i>Helicobacter pylori</i>&#8222; with &#8220;epigenetic,&#8222; &#8220;DNA methylation,&#8222; in combination with &#8220;gastric inflammation&#8222;, gastritis&#8222; and &#8220;gastric cancer&#8222; to search SCOPUS, PubMed, Ovid, and Web of Science databases. The success of epigenetic drugs such as de-methylating agents in the treatment of certain cancers has led towards new prospects that similar approaches could also be applied against gastric cancer. However, it is very important to understand the role of all the genes that have already been linked to <i>H. pylori</i>-induced DNA methylation in order to in order to evaluate the potential benefits of epigenetic drugs.https://www.mdpi.com/2076-0817/8/1/23<i>Helicobacter pylori</i>epigeneticsDNA methylationgastric cancer
spellingShingle Jibran Sualeh Muhammad
Mohamed Ahmed Eladl
Ghalia Khoder
<i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
Pathogens
<i>Helicobacter pylori</i>
epigenetics
DNA methylation
gastric cancer
title <i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
title_full <i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
title_fullStr <i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
title_full_unstemmed <i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
title_short <i>Helicobacter pylori</i>-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction
title_sort i helicobacter pylori i induced dna methylation as an epigenetic modulator of gastric cancer recent outcomes and future direction
topic <i>Helicobacter pylori</i>
epigenetics
DNA methylation
gastric cancer
url https://www.mdpi.com/2076-0817/8/1/23
work_keys_str_mv AT jibransualehmuhammad ihelicobacterpyloriiinduceddnamethylationasanepigeneticmodulatorofgastriccancerrecentoutcomesandfuturedirection
AT mohamedahmedeladl ihelicobacterpyloriiinduceddnamethylationasanepigeneticmodulatorofgastriccancerrecentoutcomesandfuturedirection
AT ghaliakhoder ihelicobacterpyloriiinduceddnamethylationasanepigeneticmodulatorofgastriccancerrecentoutcomesandfuturedirection